AFTER A SHAKY START, HYDRALLAZINE HAS NOW ESTABLISHED IT SELF Newsletter Article 12 February 2013 Pages: 2 - 2
TO BAN OR NOT TO BAN? — THE BIG AMPHETAMINE QUESTION Newsletter Article 12 February 2013 Pages: 2 - 2
EXTRAPYRAMIDAL REACTION WITH BENZQUINAMIDE: FIRST REPORT Newsletter Article 12 February 2013 Pages: 3 - 3
TOXIC EPIDERMAL NECROLYSIS WITH ORAL THIABENDAZOLE: FIRST REPORT Newsletter Article 12 February 2013 Pages: 4 - 4
RELATIVE SAFETY OF PROSTAGLANDIN ABORTIONS IS NOT YET ESTABLISHED Newsletter Article 12 February 2013 Pages: 5 - 5
BRONCHODILATORS FOR PATIENTS WITH PULMONARY DISEASE AND ARRHYTHMIA Newsletter Article 12 February 2013 Pages: 6 - 6
TWO COMMERCIAL BRANDS OF LIGNOCAINE ARE THERAPEUTICALLY EQUIVALENT Newsletter Article 12 February 2013 Pages: 7 - 7
ALTERNATE-DAY PREDNISONE NOT RECOMMENDED FOR ALOPECIA AREATA Newsletter Article 12 February 2013 Pages: 8 - 8
FAVOURABLE RESPONSES WITH DANAZOL FOR BENIGN BREAST DISORDERS Newsletter Article 12 February 2013 Pages: 9 - 9
BECLOMETHASONE DIPROPIONATE AEROSOLS IN BRONCHIAL ASTHMA Newsletter Article 12 February 2013 Pages: 9 - 9
SHOULD CEPHAZOLIN BE USED FOR STAPHYLOCOCCAL ENDOCARDITIS? Newsletter Article 12 February 2013 Pages: 9 - 9
DEGREE OF AVAILABILITY OF DEBRISOQUINE DETERMINES THE RESPONSE Newsletter Article 12 February 2013 Pages: 11 - 11